Retrospective evaluation of image-guided interventional treatments of venous and arteriovenous malformations of the face

Retrospective evaluation of image-guided interventional treatments of venous and arteriovenous malformations of the face - venous and arteriovenous malformations of the face

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026660

Enrollment

Registered

2023-01-20

Start date

2022-10-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q67.4 Q87.8

Interventions

Group 1: Retrospective analysis of data sources that include pre- and post-interventional imaging (MRI, CT, duplex sonography) of facial malformation as well as in the clinic system.

Eligibility

Sex/Gender

All

Age

4 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients diagnosed with lymphatic, arteriovenous or venous malformation of the face and having undergone image-guided treatment by sclerotherapy or embolization in the form of one or more sessions in the period from 01/01/2017 to 12/30/2021. - Patients who have received the above procedures with the following sclerotherapy/embolization agents: Polidocanol, (gelled) alcohol, EVOH-based liquid embolization agents (EVOH = ethylene vinyl alcohol copolymer), bleomycin, OK 432 (picibanil), doxycycline, STS (sodium tetradecyl sulfate).

Exclusion criteria

Exclusion criteria: - Patients with lymphatic, arteriovenous or venous malformation without facial involvement. - Patients who have received other image-guided interventional procedures, e.g., electrosclerotherapy

Design outcomes

Primary

Measure	Time frame
Retrospective evaluation of image-guided interventional treatments of venous and arteriovenous malformations of the face.	—

Secondary

Measure	Time frame
- Analysis of technical success after image-guided, interventional treatment of lymphatic, arteriovenous and venous malformations of the face (successful performance of the procedures) - Analysis of devascularization of malformations after image-guided interventional treatment of lymphatic, arteriovenous and venous malformations of the face (grading of devascularization based on pre- and post-interventional imaging) - Analysis of complication rate after image-guided interventional treatment of lymphatic, arteriovenous, and venous malformations of the face (periinterventional and postinterventional complications < 30 days).	—

Measure

Time frame

- Analysis of technical success after image-guided, interventional treatment of lymphatic, arteriovenous and venous malformations of the face (successful performance of the procedures) - Analysis of devascularization of malformations after image-guided interventional treatment of lymphatic, arteriovenous and venous malformations of the face (grading of devascularization based on pre- and post-interventional imaging) - Analysis of complication rate after image-guided interventional treatment of lymphatic, arteriovenous, and venous malformations of the face (periinterventional and postinterventional complications < 30 days).

—

Countries

Germany

Contacts

Public ContactVanessa Schmidt

Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern

Vanessa.Schmidt@med.uni-muenchen.de(089) 4400-76642

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026